MicroRNAs Control Macrophage Formation and Activation: The Inflammatory Link between Obesity and Cardiovascular

Richard Cheng-An Chang1, Wei Ying2, Fuller W Bazer2

  • 1Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, USA.

Cells
|July 12, 2014
PubMed

Insights

MicroRNAs regulate macrophages, key players in obesity-linked metabolic and cardiovascular diseases. Understanding these microRNAs offers insights into disease development and potential therapeutic targets.

Area of Science:

  • Immunology
  • Molecular Biology
  • Metabolic Disease Research

Background:

  • Resident macrophages are crucial in physiological stress responses linked to obesity, metabolic disorders, and cardiovascular diseases.
  • MicroRNAs are increasingly recognized for their regulatory roles in immune cell development and function.
  • Macrophage interactions with various tissue cells influence systemic and local physiological responses.

Purpose of the Study:

  • To review the critical roles of microRNAs in regulating macrophage development and function within the context of obesity.
  • To explore how microRNA-mediated macrophage regulation contributes to obesity-related metabolic syndrome and cardiovascular diseases.

Main Methods:

  • Literature review of recent studies on microRNAs and macrophages in obesity.
  • Analysis of microRNA involvement in monocyte formation, macrophage maturation, and tissue infiltration.
  • Examination of cell-cell interactions between macrophages and host tissue niche cells.

Main Results:

  • MicroRNAs significantly modulate key stages of macrophage biology, including their activation and recruitment.
  • Dysregulated microRNA activity in macrophages is implicated in the pathogenesis of obesity-associated conditions.
  • Macrophage interactions, influenced by microRNAs, are central to obesity-related metabolic and cardiovascular complications.

Conclusions:

  • MicroRNAs are pivotal regulators of macrophage behavior in obesity.
  • Targeting microRNAs offers a potential strategy for understanding and treating obesity-related metabolic syndrome and cardiovascular diseases.
  • Further research into microRNA-macrophage interactions is essential for advancing therapeutic interventions.